Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis
MA Björndahl, R Cao, JB Burton, E Brakenhielm… - Cancer research, 2005 - AACR
MA Björndahl, R Cao, JB Burton, E Brakenhielm, P Religa, D Galter, L Wu, Y Cao
Cancer research, 2005•AACRMetastases are commonly found in the lymphatic system. The molecular mechanism of
lymphatic metastasis is, however, poorly understood. Here we report that vascular
endothelial growth factor (VEGF)-A stimulated lymphangiogenesis in vivo and that
overexpression of VEGF-A in murine T241 fibrosarcomas induced the growth of peritumoral
lymphatic vessels, which occasionally penetrated into the tumor tissue. As a result of
peritumoral lymphangiogenesis, metastases in lymph nodes of mice were detected. VEGF-A …
lymphatic metastasis is, however, poorly understood. Here we report that vascular
endothelial growth factor (VEGF)-A stimulated lymphangiogenesis in vivo and that
overexpression of VEGF-A in murine T241 fibrosarcomas induced the growth of peritumoral
lymphatic vessels, which occasionally penetrated into the tumor tissue. As a result of
peritumoral lymphangiogenesis, metastases in lymph nodes of mice were detected. VEGF-A …
Abstract
Metastases are commonly found in the lymphatic system. The molecular mechanism of lymphatic metastasis is, however, poorly understood. Here we report that vascular endothelial growth factor (VEGF)-A stimulated lymphangiogenesis in vivo and that overexpression of VEGF-A in murine T241 fibrosarcomas induced the growth of peritumoral lymphatic vessels, which occasionally penetrated into the tumor tissue. As a result of peritumoral lymphangiogenesis, metastases in lymph nodes of mice were detected. VEGF-A–overexpressing tumors contained high numbers of infiltrating inflammatory cells such as macrophages, which are known to express VEGF receptor (VEGFR)-1. It seemed that in the mouse cornea, VEGF-A stimulated lymphangiogenesis through a VEGF-C/-D/VEGFR-3–independent pathway as a VEGFR-3 antagonist selectively inhibited VEGF-C–induced, but not VEGF-A–induced, lymphangiogenesis. Our data show that VEGF-A contributes to lymphatic mestastasis. Thus, blockage of VEGF-A–induced lymphangiogenesis may provide a novel approach for prevention and treatment of lymphatic metastasis.
AACR